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5,6-Dichloro-1-/]-D-ribofuranosylbenzimidazole  (DRB) 1  has  recently  been 
shown to inhibit selectively and reversibly the synthesis of two-thirds of nuclear 
heterogeneous RNA  (hnRNA) in mammalian cells (mouse L-929 and human 
HeLa $3) (1). The synthesis of messenger precursor RNA is highly sensitive (2), 
but there is a subfraction of hnRNA which is resistant and which is distributed 
over the entire broad size range of hnRNA (1, 2). Evidence has been obtained in 
HeLa cells that DRB inhibits the synthesis of sensitive hnRNA by blocking 
initiation of new chains  (3). DRB  (75  tLM) prevents the appearance,  in the 
cytoplasm, of almost all poly(A)-containing messenger RNA (2). 
In short-term experiments (30 min), DRB has no detectable effect on the rate 
of protein synthesis, but after treatment for a  prolonged period, the rate  of 
protein synthesis declines (1,  4,  5).  DRB  (75  ~M) inhibits the overall rate of 
cellular DNA synthesis by only 20% in short-term experiments (6). DRB does 
not block the initiation of new chains of DNA, but reduces the rate of replication 
fork progression by 20%, possibly through interference with the synthesis of 
RNA primer sequences. 
The biological activity of DRB was first detected by the inhibitory effect of the 
compound on  influenza virus  multiplication (7). The  early  studies with N- 
glycosides of benzimidazoles were undertaken because it appeared likely that 
benzimidazole ribosides would have a striking effect on virus multiplication (7). 
Fig. 1 illustrates the structure of DRB as a nucleoside analog. Any departure 
from the ~-D-ribofuranose structure in the benzimidazole glycoside was associ- 
ated with a reduction in influenza virus inhibitory activity (7-9).  However, the 
inhibitory activity of such derivatives increased with multiple substitution of 
halogen atoms in the benzenoid ring (7-9),  and the bromo-substituted deriva- 
tives were, in several instances, considerably more active than the correspond- 
ing chloro compounds (9). 
We observed early that DRB can reversibly inhibit proliferation of chick cells 
* This investigation was supported by Grant No.  CA-18608, awarded by the National Cancer 
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' Abbreviations used in this paper:  DRB,  5,6-dichloro-l-B-v-ribofuranosylbenzimidazole; FCS, 
fetal  calf  serum;  MEM,  minimal  essential  medium;  PBS,  phosphate-buffered  saline;  poly- 
(I) .poly(C), poly(inosinic acid).poly(cytidylic acid). 
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in culture without affecting cellular oxygen uptake  (7,  10,  11). Inhibition of 
proliferation of L cells has also been reported (12). Recently we have demon- 
strated that, under certain conditions, DRB can markedly increase interferon 
production by poly(I), poly(C)-induced human fibroblasts (4, 5, 13, 14). 
The purpose of the present studies was twofold: (a) to investigate quantita- 
tively the inhibition of  proliferation of human fibroblasts (neonatal foreskin cell 
strain FS-4) by DRB and two bromo-substituted 1-fl-D-ribofuranosylbenzimida- 
zoles,  i.e.,  the  5,6-dibromo  and  the  5-(or  6-)bromo-4,6-(or  5,7-)dichloro com- 
pounds; and (b) to determine the effects of these derivatives on RNA synthesis 
and on interferon production. Our results show that monobromo-dichloro-ribo- 
furanosylbenzimidazole is an extraordinarily active inhibitor of cellular RNA 
synthesis. The inhibitory effect of halogenated benzimidazole ribosides on cell 
proliferation and the enhancing (superinducing) effect on interferon production 
are likely to be mediated through the inhibition of hnRNA and messenger RNA 
(mRNA) synthesis. 
Materials and Methods 
Cell Cultures.  Cells of a  human fibroblast strain (FS-4) capable of producing interferon at a 
high level (15,  16) were grown in flasks with a 75 cm  2 growth area (3024, Falcon Plastics, Oxnard, 
Calif.) containing Eagle's minimal essential medium (MEM) (17) with 10% fetal calf serum (FCS). 
When received from Dr. Jan Vil~ek (New York University School of Medicine) the FS-4 cells were 
in their 10th passage. The present experiments were done with cells in their 12th to 17th passage. 
After reaching confluence these cells can be maintained at 37°C without change of medium for 
several  weeks.  They were passaged,  using a  4:1  subcultivation ratio,  after maintenance for a 
variable length of time in the confluent state. 
Cell growth experiments were done in multiwell tissue culture plates (Falcon 3008).  Each plate 
has four rows of six wells with a 2.1 cm  2 growth area per well. For convenience in microscopy, the 
first and last wells in each row were  not used.  FS-4 cells in a  flask were dispersed from the 
monolayer  with  0.25%  trypsin-0.05%  ethylenediaminetetraacetic  acid  (EDTA)  in  phosphate- 
buffered saline (PBS) (18) lacking Ca  +~ and Mg  +~. They were appropriately diluted and introduced 
in 1-ml vol of Eagle's MEM with 10% FCS into the wells. The plates were incubated at 37°C in a 
humidified atmosphere of 5% CO~ in air. 
Microscope Arrangement for Photography of Cells in Multiwell Culture Dishes.  An inverted 
Carl Zeiss, Inc., New York (Plankton) microscope with phase contrast optics was equipped with a 
photochanger  (473051)  which  was  used  to  split the  image  between binocular eyepieces  and a 
monocular tube.  The monocular tube transmitted the image through a  10×  periplan ocular,  a 346  CELLULAR  EFFECTS  OF  HALOBENZIMIDAZOLE  RIBOSIDES 
Leitz Microibso camera attachment with deflecting prism, focusing telescope, shutter, and a  1/3x 
cone to a Nikon 35-mm camera back (M-35 S). The cone contained a photocell that could be placed 
in the light path. The photocell was connected via a cable to a microammeter (Pace Electrical In- 
struments Co., Inc., Glendale, N. Y.). 
The well bottoms of multiwell tissue culture plates were marked with 1/8 inch circles on the 
outside  of the wells,  using a  Castell technical drawing pen and a  RapiDesign template.  Cells 
within a 0.46 mm  ~ portion of a circle in each well were enumerated using the following procedure. 
To bring a circle into concentricity with the microscopic field, a Plan 2.5 x  objective was used with 
a  Kpl 8x  ocular containing a  net micrometer disk (10  ×  10 mm; Zeiss 474062).  The sides of the 
micrometer square were superimposed on the circle making rapid centering convenient. Under a 
10 x  phase objective the circle was outside the field of view. After alignment of the phase optics, 
the cells were viewed and the microscope focused for photography using the focusing telescope of 
the Leitz Microibse camera attachment. The final magnification on the 35-ram film was 43.3x  (as 
determined by photographing the image of a stage micrometer), and the area of the culture vessel 
surface photographed was 0.46 mm  2. The light intensity and exposure times were adjusted to give 
desirable negatives and photographs. Commonly the transformer (Carl Zeiss RIW30) was at 5 V, 
and the exposure  time was 0.5  s.  Contact prints were  made for survey purposes,  but for cell 
counting the negatives were projected with a  slide projector on 8.5  x  13-inch sheets of paper and 
cells viewed and traced on paper before counting. 
Measurement of CeU Multiplication.  The technique was based on the procedure of successive 
enumeration  of cells  within marked  areas  of culture  dishes  (19).  It was  determined that  an 
inoculum of 1.25  x  104  cells in  i  ml  gave  a  suitable initial number of cells and still readily 
countable numbers several days later. On the average there were 12 cells per photograph (26 cells/ 
mm  2 of culture vessel surface) on the day after planting. In the great majority of experiments the 
24-h cell count was within the range of 20-32 ceUs/mm  s of culture vessel surface or 0.42-0.67 x  104 
cells per well after inoculation of 1.25 x  104 cells per well. The variation among the initial (24 h) 
cell counts can be ascribed largely to two factors: variation in the distribution of cells among 
different areas of a well and variation in plating efficiency from experiment to experiment. There 
was a linear relationship between 24- and 48-h cell counts in control cultures. On the 4th day after 
planting there were on the average 95 cells per photograph (207 cells/mm  2 of vessel surface) in the 
generally still subconfluent cultures. Thus, on the average the number of cells increased eightfold 
over a  3-day period of observation. 
The mean increase in cell number in control cultures between 24 and 48 h  after planting was 
1.63, giving an estimated doubling time of 29 h during this period. Cell proliferation proceeded at a 
constant exponential rate and with a doubling time of 21 h between 48 and 96 h after planting (cf. 
Figs. 2 and 4). A variable length of time (up to 2 days from planting) was required before the rate of 
increase in cell number became constant. Therefore the effects of benzimidazole derivatives on the 
rate of cell proliferation were investigated by measuring the growth rate of cells from 48 to 96 h 
after planting. 
In the Results section the cell counts are expressed in terms of numbers of cells per mm  2 of 
culture  vessel surface.  In experiments on the effects of various treatments on the rate  of cell 
proliferation,  4  fields in 4  wells were usually counted per variable, except 8  or  12 fields were 
counted in controls. Each experiment was carried out at least three times, and mean results were 
computed. 
Measurement of the Rate of RNA Synthesis.  Two confluent cultures of FS-4 cells in 35 or 60- 
mm Falcon Petri dishes were treated with 1 ml each of the test medium for 0.5 or 1 h and were then 
pulsed for 10.25 rain at 37°C with [3H]uridine (New England Nuclear, Bost., Mass., 26.7 Ci/mmol, 
50 pCi/ml) in the continued presence of the test medium. At the end of the pulse the cultures were 
rinsed 10 times with ice-cold PBS and dissolved in 1 ml of 1% sodium dodecyl sulfate. Duplicate 
aliquots of 10 ~l were used to determine total cellular radioactivity, and the remainder was used to 
measure trichloroacetic acid (10%) precipitable radioactivity (4,  20).  The rate of RNA synthesis 
was calculated as described earlier (4, 20). 
Induction  of Interferon.  Confluent  14-day-old cultures  of FS-4 cells in 60-ram Falcon Petri 
dishes were washed once with warm PBS and then treated with poly(I), poly(C) (P-L Biocbemi- 
cals,  Inc.,  Milwaukee,  Wis.)  at  a  concentration of 15  /~g/ml in  2  ml Eagle's MEM for 1 h  as 
described earlier (20). The cultures were then washed four times with warm PBS, replenished with 
2 ml maintenance medium  (Eagle's MEM supplemented with 2% heat-inactivated [56°C  for 30 IGOR  TAMM  AND  PRAVINKUMAR  B.  SEHGAL  347 
min] fetal bovine serum), and incubated at 37°C in a CO2 incubator. Cycloheximide (Polysciences, 
Inc., Warrington, Pa.), actinomycin D  (Merck Sharp & Dohme Research Laboratories, Rahway, 
N. J.),  and the benzimidazole ribosides were included in the medium at concentrations and for 
time intervals indicated in the Results section. Interferon was assayed by the semi-micro method 
of Armstrong (21) as modified by Havell and Vil~ek (15) using FS-4 cells and vesicular stomatitis 
virus. Interferon titers are expressed in terms of human reference interferon 69/19 (obtained from 
Dr. Jan Vil~ek). 
Chemicals.  DRB was obtained through the courtesy of Dr. Arthur F. Wagner, Merck Sharp & 
Dohme  Research  Laboratories.  The dibremo and the  monobromodichloro derivatives were  ob- 
tained from Dr. Karl Folkers, Merck Sharp & Dohme Research Laboratories, 20 yr ago and stored 
at room temperature before use in the present experiments.  All compounds were dissolved in 
Eagle's MEM by shaking overnight at 37°C.  The molecular weights of these compounds are as 
follows: DRB: 319.15; 5,6-dibromo-l-fl-v-ribofuranosylbenzimidazole: 408.07; 5-(or 6-)bromo-4,5-(or 
5,7-)dichloro-  1-~-D-ribofuranosylbenzimidazole: 398.06. 
Results 
Inhibition of Cell Proliferation  by Benzimidazole Ribosides.  The growth 
rate of FS-4 cells was measured in the presence of benzimidazole ribosides at 
varying concentrations, chosen on the basis of inhibitory activity on influenza 
virus multiplication (7-10). 
After planting of cells in multiwell dishes,  the cultures were  incubated for 24 h  in control 
medium before replacement of medium with fresh control medium or with compound-containing 
medium. The cultures were photographed immediately after medium change and at 24-h intervals 
thereafter over a  3-day period. In each experiment 12 control wells were examined, and 4 wells 
were used for each of the three concentrations of three compounds investigated. Results from three 
experiments were averaged. The mean cell counts per mm  2 of culture dish surface in the controls 
were as follows: 24 h: 28.7; 48 h: 50.2; 72 h: 119; and 96 h: 239. 
Fig. 2 shows the effects of 3-day treatment with benzimidazole ribosides on the 
rate of  proliferation of FS-4 cells. In control cultures the doubling time was 21 h, 
based  on  the  slope  of increase in  cell  number from 48  to  96  h.  The  three 
halobenzimidazole ribosides  investigated,  i.e.  monobromo-dichloro, dibremo, 
and dichloro, reduced the growth rate of FS-4 cells in a dose-dependent  manner. 
During the first 24-h period after addition of compounds, inconsistent results 
were obtained in several instances, whereas during the interval from 48 to 96 h 
the results were consistent and reproducible.  Two findings are noteworthy. 
First,  as  the drug concentration was  increased the  growth rate of cells de- 
creased, but remained exponential.  Second, the highest concentrations used 
with two of the compounds (3 ~M with the monobromo-dichloro and 60 ~M with 
the dichloro derivative) were sufficient largely to step cell proliferation. The 
highest concentrations of the monobromodichloro and dichloro compounds were 
50% greater than those (2 and 40 ~M, respectively) at which the doubling time of 
cells was prolonged 2.4-2.9-fold. A different dilution series was used with the 
dibromo compound, and a concentration sufficient to stop cell proliferation was 
not employed. 
Doubling times, based on the exponential growth rates of cells during the 48- 
96-h interval, are recorded in Table I. Reciprocals of doubling times were used to 
construct dose-response curves as illustrated in Fig.  3. 2 On the basis of the 
2 The reciprocal of doubling time is the exponential growth rate constant, expressed as genera- 
tions per hour (Davis,  B.  D.,  R.  Dulbecco,  H.  N.  Eisen,  H.  S.  Ginsberg,  W.  Barry Wood,  Jr. 
Microbiology, second edition. Harper and Row, Hagerstown, Md. See page 97.). It is proportional 
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FIG. 2.  Growth curves of FS-4 cells  in the presence of benzimidazole ribesides. Mono- 
bromo-dichloro refers  to 5-(or  6-)bromo-4,5-(or 5,7-)dichloro-l-~-D-ribofuranosylbenzimid- 
azole;  dibromo: 5,6-dibromo-l-B-D-ribofuranosylbenzimidazole;  dichloro:  5,6-dichloro-l-B-D- 
ribofuranosylbenzimidazole.  The numbers refer to the micromolar concentrations of the 
derivatives. 
TABLE  I 
Doubling Time of Cells in the Presence of Benzimidazole 
Derivatives  at Varying Concentrations 
Benzimidazole riboside  Cor.centration  Doubling time* 
/zM  h 
Control  -  21 
Monobromo-dichloro  1  28 
"  2  50 
3  293 
Dibromo  10  37 
"  15  62 
20  67 
Dichloro  20  35 
"  40  56 
"  60  :c 
* Based  on the  slope of increase in cell  number from 48  to 96  h  after 
planting and 24 to 72 h  after beginning of treatment. 
interpolated 50% cell growth inhibitory concentrations the relative activities of 
the monobromo-dichloro, dibromo, and dichloro derivatives are 22, 3.2, and 1, 
respectively. 
Reversibility  of the  Cell  Growth Inhibitory  Effects  of Halobenzimidazole 
Ribosides.  We have determined the kinetics of cell proliferation after a 24-h 
period of treatment with halobenzimidazole ribosides at varying concentrations. 
24  h  after planting of cells  in multiwell dishes the  medium was replaced  with fresh control 
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FIG.  3.  Relationship between concentration ofbenzimidazole ribosides and growth rate of 
FS-4 cells. Doubling times (Table I) are based on the 48-96 h  portions of growth curves 
shown in Fig. 2. 
the cultures  were photographed for  a second  time, all  media replaced with control  medium, and 
the cultures rephotographed. At 72, 96, and 168 h from planting additional  photographs were 
taken of all cultures.  In each experiment 12 wells were used for controls  and 4 wells  for each 
experimental variable.  Mean results  of  4 experiments were calculated.  The number of  cells  per 
mm 2  in  control  cultures  was as follows:  24  h: 24.9;  48 h (before  medium change): 38.6;  48 h (after 
medium change):  38.7;  72  h: 89.5;  and 96  h: 204.  At 168 h there  were too  many cells  in  a confluent 
sheet for accurate counting in control  cultures  as well as in those treated at the lowest drug 
concentration.  The cell  loss  due to  medium change at 48 h was insignificant. 
Fig.  4  shows that  the doubling time  in  control  cultures  (48-96  h from  planting) 
in this set of experiments was 21 h, a value identical  to that determined in 
experiments summarized in Fig.  2. In cultures  treated  for 24 h with the mono- 
bromo-dichloro, dibromo, or dichloro  derivative  of  benzimidazole riboside,  the 
growth of  cells  was inhibited  in a dose-dependent manner, and there was little 
or no proliferation  at the highest compound concentrations used. It should be 
noted that  with  the dibromo derivative  a concentration  series  of  7.5,  15,  and 22.5 
~M was used in these experiments, rather than the series  10, 15, and 20 ftM 
employed in the experiments summarized in Fig.  2. 
The kinetics  of cell  growth after  drug removal was characterized by two 
features: (a) the rate  of  cell  proliferation  was inversely  related  to  the drug dose 
which had been used to treat  the cells;  and (b) cell  proliferation  proceeded at 
accelerating rates,  which was most pronounced after  treatment at high dose 
levels. 
The results  in  Fig.4  clearly  show that  the inhibition  of  cell  growth by  haloben- 
zimidazole ribosides  is  substantially  reversible  upon removal of  the compounds, 350 
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FIG.  4.  Effect of 24-h treatment with benzimidazole ribosides on growth kinetics of FS-4 
cells.  The horizontal bars indicate time of treatment  with benzimidazole ribosides.  The 
numbers refer to the micromolar concentrations of the derivatives. 
and that the three derivatives used do not differ in the reversibility of their 
effect.  3 
Inhibitory  Effect  of  Halobenzimidazole  Ribosides  on  RNA  Synthe- 
sis.  Preliminary experiments indicated that  monobromo-dichloro, dibromo, 
and dichloro benzimidazole ribosides at concentrations of 3,  20,  and 60  /~M, 
respectively, inhibited the rate of  cellular RNA synthesis by approximately 60%. 
Log dose-response plots of the inhibition of RNA synthesis by the three com- 
pounds were constructed in order to determine whether the mode of action of the 
three derivatives may be similar. 
Confluent cultures of FS-4 cells in 35-mm dishes were incubated for 30 min with Eagle's MEM, 1 
ml, containing appropriate concentrations of benzimidazole derivatives. The cultures were pulsed 
with [~H]uridine for 10.25 min, and the rate of RNA synthesis was determined. All such determi- 
nations are expressed as fractions of the control rate obtained using inhibitor-free medium. 
The log dose-response plots obtained are presented in Fig. 5. It is seen that the 
three derivatives inhibit the rate of RNA synthesis by 60-70% at the highest 
concentrations tested. Furthermore, the slopes of the individual dose-response 
plots are similar. This provides presumptive evidence that the three compounds 
a The data in the present paper and in previous publications (1, 2, 5) indicate that halobenzim- 
idazole ribosides display the common characteristics of stable reversible inhibitors, in that they 
cause a  definite degree of inhibition, depending on the inhibitor concentration, which is reached 
rapidly  and  thereafter is independent of time.  (Dixon,  M.,  and E.  C.  Webb.  1964.  Enzymes. 
Academic Press, Inc., New York.  See page 316.). IGOR  TAMM  AND  PRAVINKUMAR  B.  SEHGAL  351 
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FIG.  5.  Dose-response  plots  of the inhibition of the rate  of cellular  RNA  synthesis by 
monobromo-dichloro, dibromo, and dichloro benzimidazole ribosides. 
have the  same  mode of action.  Finally,  the  relative potencies of the three 
derivatives calculated on  the  basis  of the  concentrations producing 50%  of 
maximal inhibition are 20:2.3:1 for the monobromo-dichloro (0.45 ~M), dibromo 
(4 ~M),  and dichloro (9 ~M) compounds, respectively. Similar values are ob- 
tained when the relative potencies are calculated using concentrations that 
produce 50% inhibition (Table IV). 
In additional experiments we have observed that the three compounds have 
little or no effect  on protein synthesis in cultures exposed to the drugs for 0.5 or 1 
h (not shown). Furthermore, monobromo-dichloro  ribobenzimidazole appears to 
inhibit  uridine transport to  a  lesser extent than the  dichloro compound at 
concentrations at which the synthesis of RNA is inhibited to  an equivalent 
degree (Table II)o 
Stability of  Halobenzimidazole Ribosides during Tissue Culture.  Solutions 
of the three benzimidazole compounds in Eagle's MEM with or without added 
fetal bovine serum are stable for at least 2 wk at -20°C  (data not shown). A 
proper evaluation of the cell proliferation experiments (Fig.  2  and Table I) 
requires information about the stability of these compounds during the 3-day 
period of treatment of proliferating cells.  Table II provides data that demon- 
strate  that  the  monobromo-dichloro, dibromo,  and  dichloro derivatives are 
stable under the conditions of the cell proliferation assay. 
Solutions of the three derivatives at different concentrations were made up in Eagle's MEM 
containing 10% fetal bovine serum. Half of each was used to carry out one of the cell proliferation 
experiments included in Fig.  2.  The other half was kept frozen at  -20°C  and is termed 'fresh 
medium'.  At the end of the cell proliferation experiment, the medium in the cell cultures was 
collected and cellular debris pelleted by centrifugation at 2,000 rpm in a  refrigerated centrifuge. 
The two sets of inhibitor-containing media were then tested for the ability to inhibit cellular RNA 
synthesis as described in Materials and Methods. 
The  results  presented in  Table  II  clearly show  that  inhibitor-containing 
medium obtained  after  3  days  in  tissue  culture  at  37°C was  as  potent  in 352  CELLULAR  EFFECTS  OF  HALOBENZIMIDAZOLE  RIBOSIDES 
TABLE  II 
Stability of Halobenzimidazole Ribosides During a 3-day Period of Treatment of 
Proliferating  Cells 
Compound  Concentration 
[aH]uridine  incorporation 
Total radioactivity 
TCA-precipitable radioactivity 
TCA-prec .cpra/total  cpm 
pM  cpm/dish  % of control  cpm/dish  %  % of control 
A.  Fresh medium 
None  -  1,941,000  100  45,018  2.32  100 
Monobromo~ichloro  3  1,263,300  85.1  12,696  1.00  43.1 
Dibrome  20  1,199,300  61.8  13,547  1.13  48.7 
Diehloro  80  941,850  48.5  9,469  1.00  43.1 
B.  Medium after 3 days growth of cells 
None  -  1,893,700  100  44,446  2.35  100 
Monobromo-dichioro  3  1,317,450  69.6  15,437  1.17  49.8 
Dihromo  20  1,215,200  64.2  13,986  1.15  48.9 
Dichloro  60  1,043,550  55.1  10,382  0.99  42.1 
inhibiting RNA synthesis as unused inhibitor-containing medium which had 
been kept frozen. There was also no difference  between the two sets of media in 
their ability to inhibit [3H]uridine transport. These results emphasize the fact 
that halobenzimidazole ribosides are highly stable compounds at 37°C. Further- 
more, it appears likely that these compounds are neither inactivated nor utilized 
by cells for metabolic purposes. As the volume of cells in the system is small in 
relation to  the  volume of medium,  no  detectable change in  the  compound 
concentration in the medium would be expected through simple dilution, even if 
the cells were capable of concentrating the compound. 
Enhancing  Effect  of Halobenzimidazole  Ribosides  on  Interferon  Produc- 
tion.  Earlier data  (4,  13,  14)  have shown that  the dichloro derivative can 
enhance poly(I), poly(C)-induced interferon production in FS-4 cells 50-fold. The 
enhancement of interferon yield was closely correlated with the inhibition of 
RNA synthesis. We have now measured the ability of the monobromo-dichloro 
and the dibromo derivatives to enhance interferon yields. 
Confluent FS-4 cultures in 60-ram dishes were induced with poly(I), poly(C) in the presence or 
absence of cycloheximide at 50 ~g/ml for 1 h. The rationale for the induction protocol has been 
discussed earlier (13). The cultures were washed four times with warm PBS and replenished with 2 
ml of maintenance medium with or without cycloheximide (50 ~g/ml). At 3 h after the start of the 
induction the medium in appropriate cultures was changed to one containing both cycloheximide 
and one of the benzimidazole derivatives at varying concentrations. At 4 h  after the start of the 
induction the medium in two other cultures was changed to one containing cycloheximide and 
actinomycin D  (5 ~g/ml). At 6 h  after the beginning of induction all cultures were washed four 
times with warm PBS and replenished with 2 ml of inhibitor-free maintenance medium or with 
one containing the appropriate concentration of a  benzimidazole derivative, The cultures were 
then incubated for another 18 h at the end of which time the media were harvested and assayed for 
interferon activity. Two cultures were used for each variable. 
Table HI shows that the three benzimidazole derivatives enhance interferon 
yields in a dose-dependent manner. As reported earlier (13), the dichloro com- IGOR  TAMM  AND  PRAVINKUMAR  B.  SEHGAL  353 
TABLE  III 
Enhancement of Human Interferon  Production by Halobenzimidazole 
Ribosides 
Treatment  Drug concen-  Interferon 
tration*  yields 
reference U/ml 
A.  None  -  16 
B. Cycloheximide alone  50  1,448 
C. Cycloheximide and  50 
actinomycin D  5  23,170 
D. Cycloheximide and  50 
monobromo-dichloro  1  2,896 
2  8,192 
3  16,384 
dibromo  10  4,871 
15  9,742 
20  13,777 
dichloro  20  3,444 
40  11,585 
60  11,585 
* Concentration of cycloheximide  and actinomycin D in micrograms per milli- 
liters and that of the benzimidazole derivatives in micromolar units. 
S Each titer represents the geometric mean of interferon yields between 6 and 
24 h  after induction from two cultures, each sample titrated in duplicate. 
TABLE  IV 
Action of Halobenzimidazole Ribosides 
Process  Measurement 
Concentration,  ~M  Relative  activity 
Monobromo-  Monobromo-  Dibromo  Diehloro  Dibromo  Dichloro  dichloro  dichloro 
Rate of RNA syn-  50% inhibition  1.1  10  24  22  2.4  1 
thesis 
Rate of cell prolif-  50% inhibition  1.7  12  38  22  3.2  1 
eration 
Interferon  super-  50%  of maximum  1.7  12  30  18  2.5  1 
induction  enhancement 
Influenza  virus  75% inhibition  1.8  15  38  21  2.5  1 
yield  s 
* From reference 9. 
pound at a  concentration in the range from 40 to 60 ftM produces a maximal 
enhancement. The monobromo-dichloro and the dibromo compounds produce 
close to a maximal effect at concentrations of 3 and 20 ftM, respectively. The 
maximal interferon yield obtained using any one of the three benzimidazole 
derivatives differs from that obtained by using the conventional cycloheximide- 
actinomycin D protocol (13) by at most a factor of two. The relative enhancing 
activities of the monobromo-dichloro, dibromo, and dichloro derivatives, esti- 
mated  graphically as  concentrations producing half-maximal enhancement, 
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Discussion 
There  are  two  main  questions  to  be  considered in  the  light  of the  data 
presented in the present paper and previously. Is inhibition of cell proliferation 
by halobenzimidazole ribosides mediated through inhibition of mRNA produc- 
tion? Do different halobenzimidazole ribosides act on cells the same way? There 
is now strong evidence that  the dichloro compound blocks messenger RNA 
production (2) by inhibiting the synthesis of hnRNA,  and that its action on 
hnRNA synthesis is selective (1, 22-24). The possibility has been considered that 
ORB may act at the RNA polymerase level and that there may exist a ORB- 
sensitive and an insensitive component of the RNA pelymerase responsible for 
the synthesis of hnRNA (1-3). It can be seen in Table IV that the monobromo- 
dichloro,  dibromo,  and  dichloro  derivatives of benzimidazole riboside  show 
closely similar  structure-activity relationships  with  respect to  inhibition  of 
cellular RNA synthesis and cell proliferation, and that the striking similarity in 
structure-activity relationships  extends  also  to  the  enhancing effect of the 
compounds on interferon production and to inhibition of influenza virus yield 
(9). The most likely basis for such similarity is that all three compounds act 
through the same mechanism on the processes examined. 
A  comparison of the molar concentrations at which 50%  inhibition in the 
rates of RNA synthesis and cell proliferation occurs would be arbitrary, as the 
conditions for determination of these parameters were necessarily different, and 
the effect levels for comparisons among the compounds were chosen in accord- 
ance with what appeared optimal for the different procedures used. It is note- 
worthy, however, that the concentrations at which any one of the derivatives 
produced the defined effects on RNA synthesis, cell proliferation, interferon 
production, and influenza virus yield are in fact similar. 
The hypothesis that halobenzimidazole ribosides inhibit cell proliferation by 
blocking RNA synthesis is also supported by the following evidence. With the 
dichloro compound cell proliferation is blocked at 60 ~M concentration, while at 
40 ~M it proceeds at a markedly  reduced  rate. Similarly, a maximal effect  on the 
synthesis of the drug-sensitive fraction of RNA is obtained at 60-75 ~M concen- 
tration, while a 40 ~M concentration still permits synthesis, albeit at a reduced 
rate, of such RNA (1,  3).  To obtain essentially complete inhibition of mRNA 
production, a 75 ~M concentration of the dichloro compound is required (2). The 
data on recovery of cell proliferation after a 24-h period of treatment (cf. Fig. 4) 
agree with the earlier observation that after treatment of FS-4 cells with 40 btM 
dichlorobenzimidazole riboside for 16 or 24  h  there is slow,  though complete 
recovery of protein synthesis (5). 
The close correlation between the enhancing effect of the three derivatives on 
interferon production and their inhibitory effect on RNA synthesis provides 
further  evidence  for  the  involvement of RNA  synthesis  in  the  shutoff of 
poly(I)-poly(C)-induced interferon production in FS-4 cells (4, 5, 13). The data 
also demonstrate that protocols based on any one of the three benzimidazole 
ribosides give interferon yields comparable to the conventional cycloheximide- 
actinomycin D protocol  (Table III). 
The results summarized in Table IV support the idea of a possible role for host 
RNA in the multiplication of influenza virus (7, 25), but do not permit a decision 
as to what role hnRNA may play in virus multiplication. IGOR  TAMM  AND  PRAVINKUMAR  B.  SEHGAL  355 
The very high activity of the monobromo-dichloro derivative is remarkable, as 
is the reversibility of its action, which it shares with the other derivatives. It 
appears  that  halobenzimidazole  ribosides provide  not  only a  unique  tool for 
studies of cellular biosynthesis,  but an  opportunity to explore the possibility 
that selective chemical inhibition of hnRNA synthesis, either alone or in combi- 
nation  with  other  approaches,  may be  a  useful  avenue  to  chemotherapy  of 
neoplastic disorders. No other compounds are known which offer such an oppor- 
tunity. 
Summary 
5-(or 6-)Bromo-4,5-(or  5,7-)dichloro-l-B-D-ribofuranosylbenzimidazole,  5,6-di- 
bromo-l-fl-D-ribofuranosylbenzimidazole,  and  5,6-dichloro-l-fl-D-ribofuranosyl- 
benzimidazole show closely similar structure-activity relationships with respect 
to  inhibition  of cellular  RNA synthesis,  cellular  proliferation,  and  influenza 
virus multiplication, and also with respect to enhancement of interferon produc- 
tion.  The  activities  of these  compounds  are  ranked  20:2.5:1.  The  log  dose- 
response  curves  constructed  for  inhibition  of FS-4  cell  RNA  synthesis  show 
similar slopes and a  leveling off at 60-70% inhibition of RNA synthesis at the 
highest  concentrations  of each compound tested.  This  evidence suggests that 
these three  derivatives act through  the same mechanism.  It has been shown 
previously that the dichloro compound selectively inhibits nuclear heterogenous 
RNA and messenger RNA synthesis. 
The concentrations of the benzimidazole ribosides at which the rate of prolifer- 
ation of human fibroblasts (FS-4) is reduced by 50% are as follows: monobromo- 
dichloro: 1.7  ~M (0.68 ~g/ml); dibromo: 12 ~M (4.9 ~g/ml); dichloro: 38 ~M (12 
~g/ml). All compounds reduce the exponential rate of cell proliferation in a dose- 
dependent manner.  The inhibition of cell growth is reversible upon removal of 
the compounds from the medium. 
Protocols  based  on  any  one  of the  three  halobenzimidazole  ribosides  give 
interferon yields from poly(I), poly(C)-induced FS-4 cells which are comparable 
to the high yields obtained with the conventional cycloheximide-actinomycin D 
protocol. The enhancement  of interferon yield depends on blocking of the syn- 
thesis of RNA which is involved in the shutoff of interferon production. 
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